Our teams are strengthening our swine vaccine solutions to better address the local challenges faced by professionals. Available since the end of 2024 in Germany, January 2025 in France, and soon in Austria, this new broad-spectrum vaccine allows, through the vaccination of pregnant sows, passive immunization of newborn piglets against the main pathogens responsible for neonatal diarrhea.

Our American teams have worked tirelessly alongside Emmyon, Inc. to offer an innovative ursolic acid-based solution that supports muscle health in dogs. Full details of this partnership and the resulting product can be found in the press release issued on January 07, 2025. 

Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%)